Between around 2001-2011, certain private electricity suppliers (the “smart guys”, as they were called by the press) entered into long-term (10-15 years) bilateral power purchase agreements (“PPAs”) with state-owned producers (amongst which, notably Hidroelectrica) under quite unfavorable conditions for the latter. Basically, the “smart guys” used to buy electricity from the state-owned producers at very low prices while making large profits by re-selling this cheap electricity at much higher market prices. Such PPAs were directly negotiated between the parties outside an organized market (the whole process and the contract itself being a private and confidential matter) and many of them were loss making for the selling state-owned producers (for instance, Hidroelectrica filed for insolvency and unilaterally terminated all such contracts eventually).
Bondoc si Asociatii has assisted JD Norman Industries Inc., a US-based manufacturer of steel components, with Romanian law aspects of its acquisition of REGE Automotive Brasov. The transaction, which involved the shareholdings of REGE Group in several countries, including Germany and Romania, involved financing by Wanxiang America Corporation, and Bondoc si Asociatii assisted JD Norman Industries on Romanian law aspects of that as well. Dentons advised Wanxiang America on the financing.
RTPR Allen & Overy has advise the Enterprise Investors private equity fund on the sale of the Profi Rom Food – the largest supermarket chain in Romania – to Mid Europa Partners. Dechert and Bondoc & Asociatii advised the buyers on the deal, which is reportedly the largest deal ever completed by a private equity fund in Romania and the largest deal in the retail sector in the country’s history. The transaction remains subject to approval by Romania's Competition Counsel.
Rizoiu & Poenaru, Clifford Chance, and Skadden, Arps, Slate, Meagher & Flom have advised Affidea on its acquisition of the Hiperdia diagnostics centers in Romania. Bondoc & Asociatii and Weil, Gotshal & Manges advised Hiperdia on the transaction, which remains contingent on obtaining regulatory approvals.